Mehmet Oz will likely face questions during his confirmation hearing about his past support of expanding the Medicare ...
Here’s what to know about Ozempic coverage under Medicare and other payment options available to older adults interested in trying it. While Ozempic is approved by the FDA to treat type 2 ...
Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.
Ozempic/Wegovy is the first drug on HHS's 2025 list of Medicare price negotiations. As the leaders of the pharmaceutical industry boarded their planes to come home from the JP Morgan Healthcare ...
— Days after retaining the Nickles Group, Novo Nordisk also hired Checkmate Government Relations, the new D.C. outpost of a ...
Medicare spending on some diabetes drugs, including popular treatments such as Ozempic, surged nearly five-fold to $35.8 billion between 2019 and 2023, a U.S. government watchdog's report showed ...
Novo Nordisk said it will offer all doses of Wegovy for $499 a month to patients paying cash, a bid to reach consumers who ...
The federal government has spent $6.2 billion on research and development for weight-loss drugs. Now, thanks to Big Pharma ...
The second cycle of negotiations will take place under President Donald Trump's administration. The U.S. government has said ...
Health insurance companies are lobbying against proposals that would expand prescription access to weight-loss medications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback